Literature DB >> 23453777

CLIPPERS-like MRI findings in a patient with multiple sclerosis.

R M Ferreira1, G Machado, A S Souza, K Lin, Y Corrêa-Neto.   

Abstract

Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS) has been described as a clinically and radiologically distinct pontine-predominant encephalomyelitis with a favorable response to high dose corticosteroids and usually requiring chronic immunosuppresive therapy. Brain magnetic resonance imaging (MRI) reveals a characteristic pattern of punctate and curvilinear enhancement lesions in the pons extending variably to surrounding areas. We herein describe such imaging findings in a patient with a definite diagnosis of relapsing-remitting multiple sclerosis (MS).
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23453777     DOI: 10.1016/j.jns.2013.01.032

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  11 in total

Review 1.  CLIPPERS: chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids. Review of an increasingly recognized entity within the spectrum of inflammatory central nervous system disorders.

Authors:  A Dudesek; F Rimmele; S Tesar; S Kolbaske; P S Rommer; R Benecke; U K Zettl
Journal:  Clin Exp Immunol       Date:  2014-03       Impact factor: 4.330

2.  Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids with seizures and central pyrexia, in a patient requiring tracheal intubation and mechanical ventilation: A case report.

Authors:  Rosemary J Wall
Journal:  J Intensive Care Soc       Date:  2017-07-17

3.  Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS) in limited cutaneous sclerosis: a rare disease combination.

Authors:  Sucharita Anand; Animesh Das; Surjyaprakash Shivnarayan Choudhury
Journal:  BMJ Case Rep       Date:  2019-01-07

Review 4.  Therapeutic Approaches in CLIPPERS.

Authors:  Guillaume Taieb; Thibaut Allou; Pierre Labauge
Journal:  Curr Treat Options Neurol       Date:  2017-05       Impact factor: 3.598

Review 5.  CLIPPERS.

Authors:  Nicholas L Zalewski; W Oliver Tobin
Journal:  Curr Neurol Neurosci Rep       Date:  2017-09       Impact factor: 5.081

6.  CLIPPERS: Induction and maintenance of remission using hydroxychloroquine.

Authors:  Boon Loong Tan; Marc Agzarian; David W Schultz
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2015-01-14

Review 7.  Horizontal eyeball akinesia as an initial manifestation of CLIPPERS: Case report and review of literature.

Authors:  Xiaohe Hou; Xiaoke Wang; Bo Xie; Weihong Lin; Jun Liu; Dihui Ma; Hong-Liang Zhang
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

8.  Unusual CLIPPERS presentation and role of MRI examination in the proper diagnostic assessment: A case report.

Authors:  Elena Vola; Camilla Russo; Antonio Macera; Walter Del Vecchio; Gianfranco Puoti; Ferdinando Caranci; Andrea Elefante
Journal:  Eur J Radiol Open       Date:  2019-06-06

9.  Widespread inflammation in CLIPPERS syndrome indicated by autopsy and ultra-high-field 7T MRI.

Authors:  Morten Blaabjerg; Klemens Ruprecht; Tim Sinnecker; Daniel Kondziella; Thoralf Niendorf; Bjørg Morell Kerrn-Jespersen; Mette Lindelof; Hans Lassmann; Bjarne Winther Kristensen; Friedemann Paul; Zsolt Illes
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2016-04-20

10.  Omics-Based Approach Reveals Complement-Mediated Inflammation in Chronic Lymphocytic Inflammation With Pontine Perivascular Enhancement Responsive to Steroids (CLIPPERS).

Authors:  Morten Blaabjerg; Anne Louise Hemdrup; Lylia Drici; Klemens Ruprecht; Peter Garred; Romana Höftberger; Bjarne W Kristensen; Daniel Kondziella; Tobias Sejbaek; Soren W Hansen; Helle H Nielsen; Pia Jensen; Morten Meyer; Friedemann Paul; Hans Lassmann; Martin R Larsen; Zsolt Illes
Journal:  Front Immunol       Date:  2018-04-23       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.